Robohub.org
 

José Alain Sahel, MD: Pathway Toward Vision Restoration, Artificial Vision, Artificial Retina, Optogenetics | CMU RI Seminar

by
11 February 2017



share this:

Link to video on YouTube

Abstract: “Progress in ophthalmology over the past decade moved preclinical data to clinical proof-of-concept studies bringing innovative therapeutic strategies to the market. Diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD) destroy photoreceptors but leave intact and functional a significant number of inner retinal cells. Retinal prostheses have demonstrated ability to reactivate the remaining retinal circuits at the level of bipolar or ganglion cells, after the photoreceptor loss. Recent clinical trials have demonstrated partial restoration of vision in blind people by epiretinal (Second Sight Medical Products, Pixium Vision) and subretinal (Retina Implant AG) implants, in clinical trials and practice now. Despite a limited number of electrodes, some patients were even able to read words and recognize high-contrast objects. Currently, researchers at the Stanford University and Pixium Vision in collaboration with Institut de la Vision develop a wirelessly powered photovoltaic prosthesis in which each pixel of the subretinal array directly converts patterned pulsed near-infrared light projected from video goggles into local electric current to stimulate the nearby retinal neurons. A new asynchronous dynamic visual sensor whose function mimics photoreceptor and retinal cell responses is also under development. Optogenetics (currently under preclinical evaluation in primates) and cell therapy (ongoing first safety and tolerability clinical trials with hESC- and iPSCs-derived RPE) provide alternative approaches for vision restoration in patients with advanced stages of retinal degeneration. Combination of different therapeutic strategies may offer enhanced therapeutic effectiveness and more efficient ways to save vision. These new therapeutic tools call for identification of appropriate patient selection criteria and methods to evaluate treatments’ efficiency and assess the real benefit experienced by the patients.”




John Payne





Related posts :



Robot Talk Episode 90 – Robotically Augmented People

In this special live recording at the Victoria and Albert Museum, Claire chatted to Milia Helena Hasbani, Benjamin Metcalfe, and Dani Clode about robotic prosthetics and human augmentation.
21 June 2024, by

Robot Talk Episode 89 – Simone Schuerle

In the latest episode of the Robot Talk podcast, Claire chatted to Simone Schuerle from ETH Zürich all about microrobots, medicine and science.
14 June 2024, by

Robot Talk Episode 88 – Lord Ara Darzi

In the latest episode of the Robot Talk podcast, Claire chatted to Lord Ara Darzi from Imperial College London all about robotic surgery - past, present and future.
07 June 2024, by

Robot Talk Episode 87 – Isabelle Ormerod

In the latest episode of the Robot Talk podcast, Claire chatted to Isabelle Ormerod from the University of Bristol all about human-centred design and women in robotics.
31 May 2024, by

Robot Talk Episode 86 – Mario Di Castro

In the latest episode of the Robot Talk podcast, Claire chatted to Mario Di Castro from CERN all about robotic inspection and maintenance in hazardous environments.
24 May 2024, by

Congratulations to the #ICRA2024 best paper winners

The winners and finalists in the different categories have been announced.
20 May 2024, by





Robohub is supported by:




Would you like to learn how to tell impactful stories about your robot or AI system?


scicomm
training the next generation of science communicators in robotics & AI


©2024 - Association for the Understanding of Artificial Intelligence


 












©2021 - ROBOTS Association